Metformin May Boost Glucose Excretion in Stool
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 12, 2020 Category: General Medicine Source Type: news
Marksans Pharma recalls 11,279 bottles of diabetes drug due to cancer causing chemical
The company has issued voluntary recall of one batch of Metformin extended release tablets (USP 500 mg) due to detection of NDMA (N-nitrosodimethylamine), Marksans Pharma said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 7, 2020 Category: Pharmaceuticals Source Type: news
Marksans Pharma Limited Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg, Due to the Detection of N-Nitrosodimethylamine (NDMA)
Marksans Pharma Limited, India is voluntarily recalling Metformin Hydrochloride Extended-Release Tablets, USP 500mg, lot # XP9004, to the consumer level. FDA analysis has found the product to contain N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit (ADI) of 96ng/da (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 5, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Teva Pharmaceuticals USA, Inc. Initiates Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP 500 mg and 750 mg Due to Detection of N-Nitrosodimethylamine (NDMA)
Teva Pharmaceuticals USA, Inc. is voluntarily recalling fourteen (14) lots of Metformin Hydrochloride Extended-Release Tablets, USP 500 mg and 750 mg, 100 and 1000 count bottles, in the United States to the consumer-level due to the detection of N-Nitrosodimethylamine (NDMA) levels in excess of the (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 5, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Activation of AMP-activated protein kinase during sepsis/inflammation improves survival by preserving cellular metabolic fitness
The purpose was to determine the role of AMPK activation in the renal metabolic response to sepsis, the development of sepsis-induced acute kidney injury (AKI) and on survival. In a prospective experimental study, 167 10- to 12-week-old C57BL/6 mice underwent cecal ligation and puncture (CLP) and human proximal tubule epithelial cells (TEC; HK2) were exposed to inflammatory mix (IM), a combination of lipopolysaccharide (LPS) and high mobility group box 1 (HMGB1). Renal/TEC metabolic fitness was assessed by monitoring the expression of drivers of oxidative phosphorylation (OXPHOS), the rates of utilization of OXPHOS/glycoly...
Source: Current Awareness Service for Health (CASH) - June 4, 2020 Category: Consumer Health News Source Type: news
Amneal Pharmaceuticals LLC Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended Release Tablets, USP, 500 mg and 750 mg, Due to Detection of N-Nitrosodimethylamine (NDMA) Impurity
Amneal Pharmaceuticals LLC Bridgewater, New Jersey (Amneal), is voluntarily recalling all lots of Metformin Hydrochloride Extended Release Tablets, USP, 500 mg and 750 mg, within expiry to the Retail Level.
Amneal was notified by the U.S. FDA that the Agency ’s testing of seven lots of Metformin Hydr (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 1, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Metformin Recalled for Possible Cancerous Chemical
The recall for all lots of metformin hydrochloride extended-release tablets 500 mg from Apotex comes after one lot tested by the U.S. Food and Drug Administration had higher NDMA levels than allowed by the FDA. (Source: WebMD Health)
Source: WebMD Health - June 1, 2020 Category: Consumer Health News Source Type: news
FDA Issues Recall Alert for Metformin ER Products
The FDA is asking several pharmaceutical companies to voluntarily recall products containing extended-release formulations of metformin, a drug prescribed to millions of patients with type 2 diabetes. (Source: AAFP News)
Source: AAFP News - June 1, 2020 Category: Primary Care Source Type: news
FDA Finds Contamination In Several Brands Of Diabetes Drug
U.S. health regulators are telling five drugmakers to recall their versions of metformin, a widely used diabetes medication. (Source: Science - The Huffington Post)
Source: Science - The Huffington Post - May 29, 2020 Category: Science Source Type: news
Metformin Recalled Due to Potential Cancer-Causing Chemical
FRIDAY, May 29, 2020 -- A recall of the widely used diabetes drug metformin was announced by drug maker Apotex due to possible high levels of N-Nitrosodimethylamine (NDMA), which is believed to cause cancer in people.
The recall for all lots of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 29, 2020 Category: Pharmaceuticals Source Type: news
Diabetes and COVID-19 Link
I have results from my clinic…
Three of my diabetic patients went into remission after using hyperbaric oxygen therapy (HBOT).
Two patients had type 1 diabetes… and another had type 2 diabetes. All three recovered with oxygen therapy.
Most mainstream doctors would scoff at the idea… they “know” there’s no cure for diabetes. And to be treated for it with oxygen seems laughable.
If you’re a regular reader, you know more about oxygen therapy than 99% of the general public, including most doctors.
But the reason diabetes responds so well to oxygen may surprise you…
It also explains why ...
Source: Al Sears, MD Natural Remedies - May 29, 2020 Category: Complementary Medicine Authors: Dr.A.Sears Tags: Health Source Type: news
Metformin Linked to Better Motor Function in Parkinson's Metformin Linked to Better Motor Function in Parkinson's
Patients with Parkinson ' s disease and diabetes treated with metformin experience better motor and nonmotor function than those not receiving the antihyperglycemic agent, pilot data suggest.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - May 29, 2020 Category: Primary Care Tags: Neurology & Neurosurgery News Source Type: news
FDA Recall Extended-Release Metformin Due to NDMA Impurities FDA Recall Extended-Release Metformin Due to NDMA Impurities
The FDA advises voluntary recall of extended-release metformin made by five manufacturers after NDMA contamination found in some batches.News Alerts (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - May 29, 2020 Category: Primary Care Tags: Diabetes & Endocrinology News Alert Source Type: news
FDA Recalls Extended-Release Metformin Due to NDMA Impurities FDA Recalls Extended-Release Metformin Due to NDMA Impurities
The FDA advises voluntary recall of extended-release metformin made by five manufacturers after NDMA contamination found in some batches.News Alerts (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - May 29, 2020 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Alert Source Type: news
U.S. FDA asks five firms to recall diabetes drug with high levels of probable carcinogen
The U.S. Food and Drug Administration (FDA) said on Thursday it has recommended five pharmaceutical firms to voluntarily recall their diabetes drug metformin after the agency found high levels of a possible cancer-causing impurity in some versions of the medication. (Source: Reuters: Health)
Source: Reuters: Health - May 29, 2020 Category: Consumer Health News Tags: healthNews Source Type: news
